Flamingo Therapeutics

Foundation date

04/07/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

The core business of Flamingo Therapeutics is the development of novel and innovative drugs for specific cancer types.

Upcoming events

Latest news

  • Triple discovery unveils insights into type 2 diabetes

    Thursday September 28th 2023

  • SwiftPharma and Medace sign strategic collaboration agreement for biomanufacturing and purification of promising medicinal proteins.

    Wednesday September 27th 2023

  • Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen

    Wednesday September 27th 2023